Bridgeway Capital Management LLC Has $1.42 Million Holdings in LifeVantage Co. (NASDAQ:LFVN)

Bridgeway Capital Management LLC cut its position in shares of LifeVantage Co. (NASDAQ:LFVN - Free Report) by 27.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 80,766 shares of the company's stock after selling 29,999 shares during the period. Bridgeway Capital Management LLC owned 0.64% of LifeVantage worth $1,416,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in LFVN. LPL Financial LLC raised its holdings in LifeVantage by 301.0% during the fourth quarter. LPL Financial LLC now owns 211,039 shares of the company's stock valued at $3,700,000 after buying an additional 158,405 shares in the last quarter. Susquehanna International Group LLP grew its position in shares of LifeVantage by 83.5% in the fourth quarter. Susquehanna International Group LLP now owns 128,082 shares of the company's stock valued at $2,245,000 after purchasing an additional 58,279 shares during the last quarter. American Century Companies Inc. grew its position in shares of LifeVantage by 50.5% in the fourth quarter. American Century Companies Inc. now owns 95,552 shares of the company's stock valued at $1,675,000 after purchasing an additional 32,055 shares during the last quarter. O Shaughnessy Asset Management LLC grew its position in shares of LifeVantage by 56.2% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 93,576 shares of the company's stock valued at $1,640,000 after purchasing an additional 33,658 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its position in shares of LifeVantage by 43.9% in the fourth quarter. Bank of New York Mellon Corp now owns 74,183 shares of the company's stock valued at $1,300,000 after purchasing an additional 22,620 shares during the last quarter. 35.32% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Craig Hallum started coverage on LifeVantage in a research report on Tuesday, January 14th. They issued a "buy" rating and a $35.00 price target on the stock.

LifeVantage Stock Performance

Shares of NASDAQ:LFVN traded up $0.43 during midday trading on Wednesday, hitting $12.56. The company's stock had a trading volume of 143,572 shares, compared to its average volume of 139,789. LifeVantage Co. has a fifty-two week low of $5.22 and a fifty-two week high of $27.38. The stock has a market capitalization of $158.11 million, a price-to-earnings ratio of 22.43 and a beta of 0.41. The stock's 50 day simple moving average is $14.08 and its 200 day simple moving average is $16.31.

LifeVantage (NASDAQ:LFVN - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.10. LifeVantage had a return on equity of 34.29% and a net margin of 3.46%. The firm had revenue of $58.44 million for the quarter, compared to analyst estimates of $60.99 million.

LifeVantage Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, June 13th. Investors of record on Friday, May 30th will be paid a dividend of $0.045 per share. This represents a $0.18 annualized dividend and a yield of 1.43%. This is a positive change from LifeVantage's previous quarterly dividend of $0.04. The ex-dividend date of this dividend is Friday, May 30th. LifeVantage's payout ratio is currently 26.09%.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.